<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30212931</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>09</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-5964</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>97</Volume>                    <Issue>37</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Medicine</Title>                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>            </Journal>            <ArticleTitle>Exploring the molecular mechanism associated with breast cancer bone metastasis using bioinformatic analysis and microarray genetic interaction network.</ArticleTitle>            <Pagination>                <MedlinePgn>e12032</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000012032</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Bone metastases are common in advanced breast cancer patients and frequently leading to skeletal-related morbidity and deterioration in the quality of life. Although chemotherapy and hormone therapy are able to control the symptoms caused by bone destruction, the underlying molecular mechanisms for the affinity of breast cancer cells towards skeletal bones are still not completely understood.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">In this study, bioinformatic analysis was performed on patients' microarray gene expression data to explore the molecular mechanism associated with breast cancer bone metastasis. Microarray gene expression profile regarding patients with breast cancer and disseminated tumor cells was downloaded from Gene Expression Omnibus (GEO) database (NCBI, NIH). Raw data were normalized and differently expressed genes were identified by using Significance Analysis of Microarrays (SAM) methods. Protein interaction networks were expanded using String. Moreover, molecular functions, biological processes and signaling pathway enrichment analysis were performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 66 differentially expressed genes. After submitting the set of genes to String, genetic interaction network was expanded, which consisted of 110 nodes and 869 edges. Pathway enrichment analysis suggested that adhesion kinase, ECM-receptor interaction, calcium signaling, Wnt pathways, and PI3K/AKT signaling pathway are highly associated with breast cancer bone metastasis.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this study, we established a microarray genetic interaction network associated with breast cancer bone metastasis. This information provides some potential molecular therapeutic targets for breast cancer initiation and progression.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Xinhua</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Fujian Cancer Hospital &amp; Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pei</LastName>                    <ForeName>Zhe</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Duke University Medical School, Durham, NC.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Peng</LastName>                    <ForeName>Hao</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Guangxi Key Laboratory of Veterinary Biotechnology, Guangxi, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zheng</LastName>                    <ForeName>Zhihong</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Medicine (Baltimore)</MedlineTA>            <NlmUniqueID>2985248R</NlmUniqueID>            <ISSNLinking>0025-7974</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Lett. 2017 Feb;13(2):955-960</RefSource>                <PMID Version="1">28356984</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onco Targets Ther. 2017 Mar 01;10:1327-1334</RefSource>                <PMID Version="1">28280367</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Exp Metastasis. 2009;26(8):935-43</RefSource>                <PMID Version="1">19697143</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Jun 02;9(6):e98229</RefSource>                <PMID Version="1">24886783</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Microenviron. 2014 Aug;7(1-2):71-8</RefSource>                <PMID Version="1">24858419</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2004 Oct;165(4):1087-95</RefSource>                <PMID Version="1">15466376</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biochem. 2015 Jul;116(7):1411-8</RefSource>                <PMID Version="1">25754581</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Molecules. 2017 Mar 28;22(4):</RefSource>                <PMID Version="1">28350337</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Mar 22;7(12):13520-37</RefSource>                <PMID Version="1">26575329</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biol. 2012 Feb 20;196(4):395-406</RefSource>                <PMID Version="1">22351925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2016 Apr 8;352(6282):167-9</RefSource>                <PMID Version="1">27124449</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Biol (Camb). 2012 Aug;4(8):897-904</RefSource>                <PMID Version="1">22722498</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Biochem Biophys. 2015 May;72(1):171-7</RefSource>                <PMID Version="1">27040945</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathol Oncol Res. 2016 Jul;22(3):471-6</RefSource>                <PMID Version="1">26608797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Jul 23;5:12363</RefSource>                <PMID Version="1">26201295</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Discov. 2012 Aug;2(8):706-21</RefSource>                <PMID Version="1">22609699</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Gynecol Cancer. 2003 Sep-Oct;13(5):640-6</RefSource>                <PMID Version="1">14675348</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1991 Mar;9(3):509-24</RefSource>                <PMID Version="1">1705581</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jan 17;8(3):4449-4459</RefSource>                <PMID Version="1">27966458</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Ethnopharmacol. 2016 Jul 21;188:111-22</RefSource>                <PMID Version="1">27178635</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2004 Feb;4(2):118-32</RefSource>                <PMID Version="1">14964308</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 Jun 25;8(6):e67142</RefSource>                <PMID Version="1">23825635</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2001 May 17;411(6835):375-9</RefSource>                <PMID Version="1">11357145</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29</RefSource>                <PMID Version="1">12838335</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2014 Sep;14(9):598-610</RefSource>                <PMID Version="1">25098269</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2007 Jul;7(7):519-30</RefSource>                <PMID Version="1">17585332</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2001 Oct;1(1):46-54</RefSource>                <PMID Version="1">11900251</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2003 Sep-Oct;23(5A):3937-44</RefSource>                <PMID Version="1">14666700</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2012 Sep 14;287(38):31666-73</RefSource>                <PMID Version="1">22822055</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Oct 22;378(9801):1461-84</RefSource>                <PMID Version="1">21924486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2011 Jul 22;11(8):609-18</RefSource>                <PMID Version="1">21779011</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onco Targets Ther. 2015 Jun 09;8:1387-98</RefSource>                <PMID Version="1">26089687</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2014 Sep;1842(9):1742-54</RefSource>                <PMID Version="1">24970744</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129</RefSource>                <PMID Version="1">20457567</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Syst Biol. 2012 Dec 10;6:152</RefSource>                <PMID Version="1">23228038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2013 Aug;22 Suppl 2:S66-72</RefSource>                <PMID Version="1">24074795</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biol. 2000 May 1;149(3):741-54</RefSource>                <PMID Version="1">10791986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Mol Pathol. 2014 Dec;97(3):535-41</RefSource>                <PMID Version="1">25445499</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Dis. 2014 Apr 10;5:e1155</RefSource>                <PMID Version="1">24722280</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2002 Jul;2(7):521-8</RefSource>                <PMID Version="1">12094238</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004843" MajorTopicYN="N">Epistasis, Genetic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30212931</ArticleId>            <ArticleId IdType="doi">10.1097/MD.0000000000012032</ArticleId>            <ArticleId IdType="pii">00005792-201809140-00008</ArticleId>            <ArticleId IdType="pmc">PMC6156059</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>